Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Mario Cappiello, Francesco Balestri, Roberta Moschini, Umberto Mura & Antonella Del-Corso. (2020) Intra-site differential inhibition of multi-specific enzymes. Journal of Enzyme Inhibition and Medicinal Chemistry 35:1, pages 840-846.
Read now
Read now
Eirini Chainoglou & Dimitra Hadjipavlou-Litina. (2019) Curcumin analogues and derivatives with anti-proliferative and anti-inflammatory activity: Structural characteristics and molecular targets. Expert Opinion on Drug Discovery 14:8, pages 821-842.
Read now
Read now
Michael Plioukas, Chrysi Gabrieli, Diamanto Lazari & Eugene Kokkalou. (2016) Phytochemical analysis with the antioxidant and aldose reductase inhibitory capacities of Tephrosia humilis aerial parts’ extracts. Natural Product Research 30:12, pages 1366-1372.
Read now
Read now
Ivana Milackova, Marta Soltesova Prnova, Magdalena Majekova, Ruzena Sotnikova, Michal Stasko, Lucia Kovacikova, Sreeparna Banerjee, Miroslav Veverka & Milan Stefek. (2015) 2-Chloro-1,4-naphthoquinone derivative of quercetin as an inhibitor of aldose reductase and anti-inflammatory agent. Journal of Enzyme Inhibition and Medicinal Chemistry 30:1, pages 107-113.
Read now
Read now
Articles from other publishers (31)
Wei Shi, Guang Xu, Yuan Gao, Jun Zhao, Tingting Liu, Jia Zhao, Huijie Yang, Ziying Wei, Hui Li, An-Long Xu, Zhaofang Bai & Xiaohe Xiao. (2023) Novel role for epalrestat: protecting against NLRP3 inflammasome-driven NASH by targeting aldose reductase. Journal of Translational Medicine 21:1.
Crossref
Crossref
Tongshuai Zhang, Jinrong Wu, Xinmin Yao, Yao Zhang, Yue Wang, Yang Han, Yun Wu, Zhenyu Xu, Jing Lan, Siyu Han, Haifeng Zou, Qixu Sun, Dandan Wang, Jingyu Zhang & Guangyou Wang. (2023) The Aldose Reductase Inhibitor Epalrestat Maintains Blood–Brain Barrier Integrity by Enhancing Endothelial Cell Function during Cerebral Ischemia. Molecular Neurobiology 60:7, pages 3741-3757.
Crossref
Crossref
Mishal Rao, Yu-Kai Huang, Chia-Chun Liu, Chandler Meadows, Hui-Chun Cheng, Mengli Zhou, Yu-Chih Chen, Xin Xia, Jeffrey L. Goldberg, Andrew M. Williams, Takaaki Kuwajima & Kun-Che Chang. (2023) Aldose reductase inhibition decelerates optic nerve degeneration by alleviating retinal microglia activation. Scientific Reports 13:1.
Crossref
Crossref
Li Ding, Jianyu Yan, Tengfei Li, Zhenyuan Miao, Huanhai Liu & Chunlin Zhuang. 2023. Privileged Scaffolds in Drug Discovery. Privileged Scaffolds in Drug Discovery
41
63
.
Ankush Kharyal, Sanjeev Ranjan, Shalini Jaswal, Darakhshan Parveen, Ghanshyam Das Gupta, Suresh Thareja & Sant Kumar Verma. (2022) Research progress on 2,4-thiazolidinedione and 2-thioxo-4-thiazolidinone analogues as aldose reductase inhibitors. Journal of Molecular Structure 1269, pages 133742.
Crossref
Crossref
Ke Zhong, Yu Huang, Prince last Mudenda Zilundu, Yaqiong Wang, Yingying Zhou, Guangyin Yu, Rao Fu, Sookja Kim Chung, Yamei Tang, Xiao Cheng & Lihua Zhou. (2022) Motor neuron survival is associated with reduced neuroinflammation and increased autophagy after brachial plexus avulsion injury in aldose reductase-deficient mice. Journal of Neuroinflammation 19:1.
Crossref
Crossref
Francesco Balestri, Giulio Poli, Lucia Piazza, Mario Cappiello, Roberta Moschini, Giovanni Signore, Tiziano Tuccinardi, Umberto Mura & Antonella Del Corso. (2022) Dissecting the Activity of Catechins as Incomplete Aldose Reductase Differential Inhibitors through Kinetic and Computational Approaches. Biology 11:9, pages 1324.
Crossref
Crossref
Aqeel Imran, Muhammad Tariq Shehzad, Syed Jawad Ali Shah, Mark Laws, Taha al-Adhami, Khondaker Miraz Rahman, Imtiaz Ali Khan, Zahid Shafiq & Jamshed Iqbal. (2022)
Development, Molecular Docking, and
In Silico
ADME Evaluation of Selective ALR2 Inhibitors for the Treatment of Diabetic Complications
via
Suppression of the Polyol Pathway
. ACS Omega 7:30, pages 26425-26436.
Crossref
Crossref
Kun Zhang, Wen-Can Lu, Ming Zhang, Qian Zhang, Pan-Pan Xian, Fang-Fang Liu, Zhi-Yang Chen, ChungSookja Kim, Sheng-Xi Wu, Hui-Ren Tao & Ya-Zhou Wang. (2022) Reducing host aldose reductase activity promotes neuronal differentiation of transplanted neural stem cells at spinal cord injury sites and facilitates locomotion recovery. Neural Regeneration Research 17:8, pages 1814.
Crossref
Crossref
Angeline Julius, Remya Rajan Renuka, Waheeta Hopper & Raghu Babu Pothireddy. (2022) Anti-inflammatory Compounds Inhibit Aldose Reductase: A Potential Target for Cancer. Results in Chemistry 4, pages 100382.
Crossref
Crossref
Muhammad Tariq Shehzad, Ajmal Khan, Sobia Ahsan Halim, Abdul Hameed, Aqeel Imran, Jamshed Iqbal, Aziz Ullah, Asnuzilawati Asari, Samra Khan, Zahid Shafiq & Ahmed Al-Harrasi. (2021)
Synthesis of indole-substituted thiosemicarbazones as an aldose reductase inhibitor: an
in vitro
, selectivity and
in silico
study
. Future Medicinal Chemistry 13:14, pages 1185-1201.
Crossref
Crossref
Sapna Thakur, Sonu Kumar Gupta, Villayat Ali, Priyanka Singh & Malkhey Verma. (2021) Aldose Reductase: a cause and a potential target for the treatment of diabetic complications. Archives of Pharmacal Research 44:7, pages 655-667.
Crossref
Crossref
Lucia Kovacikova, Marta Soltesova Prnova, Magdalena Majekova, Andrej Bohac, Cimen Karasu & Milan Stefek. (2021) Development of Novel Indole-Based Bifunctional Aldose Reductase Inhibitors/Antioxidants as Promising Drugs for the Treatment of Diabetic Complications. Molecules 26:10, pages 2867.
Crossref
Crossref
S. M. Holota, I. O. Nektegayev, I. I. Soronovych, I. I. Chubuchna, M. A. Kolishetska, S. P. Sysak, M. S. Regeda & R. B. Lesyk. (2021) The novel pyrazolin-5-one bearing thiazolidin-4-ones: synthesis, characterization and biological evaluation. Biopolymers and Cell 37:1, pages 46-61.
Crossref
Crossref
Bahare Salehi, Cristina Quispe, Imane Chamkhi, Nasreddine El Omari, Abdelaali Balahbib, Javad Sharifi-Rad, Abdelhakim Bouyahya, Muhammad Akram, Mehwish Iqbal, Anca Oana Docea, Constantin Caruntu, Gerardo Leyva-Gómez, Abhijit Dey, Miquel Martorell, Daniela Calina, Víctor López & Francisco Les. (2021) Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence. Frontiers in Pharmacology 11.
Crossref
Crossref
Canmao Wang, Lei La, Haixing Feng, Qin Yang, Fuling Wu, Chunxia Wang, Jiangjie Wu, Lianbing Hou, Chuqi Hou & Wenqin Liu. (2020) Aldose Reductase Inhibitor Engeletin Suppresses Pelvic Inflammatory Disease by Blocking the Phospholipase C/Protein Kinase C-Dependent/NF-κB and MAPK Cascades. Journal of Agricultural and Food Chemistry 68:42, pages 11747-11757.
Crossref
Crossref
Muhammad Tariq Shehzad, Abdul Hameed, Mariya al-Rashida, Aqeel Imran, Maliha Uroos, Asnuzilawati Asari, Habsah Mohamad, Muhammad Islam, Shafia Iftikhar, Zahid Shafiq & Jamshed Iqbal. (2019) Exploring antidiabetic potential of adamantyl-thiosemicarbazones via aldose reductase (ALR2) inhibition. Bioorganic Chemistry 92, pages 103244.
Crossref
Crossref
Morgan A. Alford, Zhenlin Tian, Frederic Menard & Andis Klegeris. (2019) Characterization of novel kainic acid analogs as inhibitors of select microglial functions. European Journal of Pharmacology 851, pages 25-35.
Crossref
Crossref
Himangshu Sonowal, Ashish Saxena & Kota V. Ramana. 2019. Oxidative Stress in Lung Diseases. Oxidative Stress in Lung Diseases
225
246
.
Rosanna Maccari, Antonella Del Corso, Paolo Paoli, Ilenia Adornato, Giulia Lori, Francesco Balestri, Mario Cappiello, Alexandra Naß, Gerhard Wolber & Rosaria Ottanà. (2018) An investigation on 4-thiazolidinone derivatives as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the search for potential agents for the treatment of type 2 diabetes mellitus and its complications. Bioorganic & Medicinal Chemistry Letters 28:23-24, pages 3712-3720.
Crossref
Crossref
Juan F. Rivelli, Ana L. Ochoa, Verónica S. Santander, Ayelen Nigra, Gabriela Previtali & César H. Casale. (2018) Regulation of aldose reductase activity by tubulin and phenolic acid derivates. Archives of Biochemistry and Biophysics 654, pages 19-26.
Crossref
Crossref
Kamel Metwally, Harris Pratsinis, Dimitris Kletsas, Luca Quattrini, Vito Coviello, Concettina La Motta, Ahmed A El-Rashedy & Mahmoud ES Soliman. (2017) Novel quinazolinone-based 2,4-thiazolidinedione-3-acetic acid derivatives as potent aldose reductase inhibitors. Future Medicinal Chemistry 9:18, pages 2147-2166.
Crossref
Crossref
Hina Andleeb, Yildiz Tehseen, Farrukh Jabeen, Imtiaz Khan, Jamshed Iqbal & Shahid Hameed. (2017) Exploration of thioxothiazolidinone–sulfonate conjugates as a new class of aldehyde/aldose reductase inhibitors: A synthetic and computational investigation. Bioorganic Chemistry 75, pages 1-15.
Crossref
Crossref
Jia-Xing Zhao, Ya-Wei Yuan, Cheng-Fu Cai, Dong-Yan Shen, Mao-Li Chen, Feng Ye, Yan-Jun Mi, Qi-Cong Luo, Wang-Yu Cai, Wei Zhang, Ying Long, Yong Zeng, Guo-Dong Ye & Shu-Yu Yang. (2017) Aldose reductase interacts with AKT1 to augment hepatic AKT/mTOR signaling and promote hepatocarcinogenesis. Oncotarget 8:40, pages 66987-67000.
Crossref
Crossref
Chunlin Zhuang, Wen Zhang, Chunquan Sheng, Wannian Zhang, Chengguo Xing & Zhenyuan Miao. (2017) Chalcone: A Privileged Structure in Medicinal Chemistry. Chemical Reviews 117:12, pages 7762-7810.
Crossref
Crossref
Nikolaos Papastavrou, Maria Chatzopoulou, Jana Ballekova, Mario Cappiello, Roberta Moschini, Francesco Balestri, Alexandros Patsilinakos, Rino Ragno, Milan Stefek & Ioannis Nicolaou. (2017) Enhancing activity and selectivity in a series of pyrrol-1-yl-1-hydroxypyrazole-based aldose reductase inhibitors: The case of trifluoroacetylation. European Journal of Medicinal Chemistry 130, pages 328-335.
Crossref
Crossref
Amir Hakim & Omar Usmani. 2016. Advances in Pulmonary Drug Delivery. Advances in Pulmonary Drug Delivery
49
66
.
Francesco Balestri, Mario Cappiello, Roberta Moschini, Rossella Rotondo, Marco Abate, Antonella Del-Corso & Umberto Mura. (2015) Modulation of aldose reductase activity by aldose hemiacetals. Biochimica et Biophysica Acta (BBA) - General Subjects 1850:11, pages 2329-2339.
Crossref
Crossref
Milan Stefek, Marta Soltesova Prnova, Magdalena Majekova, Chris Rechlin, Andreas Heine & Gerhard Klebe. (2015) Identification of Novel Aldose Reductase Inhibitors Based on Carboxymethylated Mercaptotriazinoindole Scaffold. Journal of Medicinal Chemistry 58:6, pages 2649-2657.
Crossref
Crossref
Maria Chatzopoulou, Alexandros Patsilinakos, Theodosia Vallianatou, Marta Soltesova Prnova, Simon Žakelj, Rino Ragno, Milan Stefek, Albin Kristl, Anna Tsantili-Kakoulidou & Vassilis J. Demopoulos. (2014) Decreasing acidity in a series of aldose reductase inhibitors: 2-Fluoro-4-(1H-pyrrol-1-yl)phenol as a scaffold for improved membrane permeation. Bioorganic & Medicinal Chemistry 22:7, pages 2194-2207.
Crossref
Crossref
Mario Cappiello, Roberta Moschini, Francesco Balestri, Umberto Mura & Antonella Del-Corso. (2014) Basic models for differential inhibition of enzymes. Biochemical and Biophysical Research Communications 445:3, pages 556-560.
Crossref
Crossref